首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

2084712

鼻腔給藥市場：依治療應用、劑型、容器類型、系統類型、最終用戶、通路和地區分類。

Nasal Drug Delivery Mode Market, By Therapeutic Application, By Dosage Form, By Container Type, By System Type, By End Users, By Distribution Channel, By Geography

出版日期: 2026年06月16日 | 出版商:

Coherent Market Insights | 英文 259 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，鼻腔給藥市場規模將達到 676 億美元，到 2033 年將達到 1,003 億美元。預計 2026 年至 2033 年的複合年成長率為 5.8%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	676億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	5.80%	預計金額（2033 年）	1003億美元

藥物遞送是指將藥物輸送到目標部位進行釋放和吸收的技術。鼻腔給藥可使藥物快速起效（局部或全身）。鼻內給藥是局部鼻腔給藥最常用的方法，可用於局部減充血劑和抗發炎藥物。鼻腔給藥是治療鼻腔和鼻竇疾病的合理選擇。多年來，鼻腔給藥途徑作為一種有前景的口服和腸外給藥替代方案，已引起廣泛關注。

市場動態

氣喘和慢性阻塞性肺病（COPD）盛行率的不斷上升、患者自行用藥的日益普及以及鼻腔給藥方式的日益受到青睞，是預計在預測期內推動全球鼻腔給藥市場成長的關鍵因素。氣喘是一種影響兒童和成人的主要非傳染性疾病（NCD）。例如，根據美國氣喘和過敏基金會（AAFA）的數據，美國有超過2500萬人患有氣喘，約占美國人口的十三分之一。此外，美國有超過2,000萬18歲及以上的成年人患有氣喘，其中黑人成年人的氣喘最高。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球鼻腔給藥市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球鼻腔給藥市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球鼻腔給藥市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第11章競爭格局

熱圖分析
市佔率分析
公司簡介
- Merck & Co., Inc.
- AstraZeneca
- GlaxoSmithKline plc（GSK）
- Mystic Pharmaceuticals
- Johnson & Johnson Services Inc.
- PendoPharm Inc.
- Bausch Health Companies Inc.
- 3M Company
- Cadila Pharmaceuticals Ltd.
- OptiNose Inc.
- Dr. Reddy's Laboratories Ltd.
- ENT Technologies Pty Ltd.
- Neurelis Inc.
- AptarGroup, Inc.
- Becton, Dickinson and Company
分析師意見

第12章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5047

Nasal Drug Delivery Mode Market is estimated to be valued at USD 67.6 Bn in 2026 and is expected to reach USD 100.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 67.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 100.3 Bn

Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.

Market Dynamics

Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.

Market Segmentation

By Therapeutic Application (Revenue, USD Bn, 2021-2033)
Asthma
Rhinitis
Others
By Dosage Form (Revenue, USD Bn, 2021-2033)
Powder
Spray
Gel
By Container Type (Revenue, USD Bn, 2021-2033)
Pressurized Container
Non Pressurized
Container
By System Type (Revenue, USD Bn, 2021-2033)
Multi- Dose
Bi-Dose
Unit Dose
By End Users (Revenue, USD Bn, 2021-2033)
Hospitals
Homecare Settings
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Merck & Co., Inc.
AstraZeneca
GlaxoSmithKline plc (GSK)
Mystic Pharmaceuticals
Johnson & Johnson Services Inc.
PendoPharm Inc.
Bausch Health Companies Inc.
3M Company
Cadila Pharmaceuticals Ltd.
OptiNose Inc.
Reddy's Laboratories Ltd.
ENT Technologies Pty Ltd.
Neurelis Inc.
AptarGroup, Inc.
Becton, Dickinson and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By System Type
- Market Snapshot, By End Users
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Nasal Drug Delivery Mode Market, By Therapeutic Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Nasal Drug Delivery Mode Market, By Dosage Form, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Nasal Drug Delivery Mode Market, By Container Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pressurized Container
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Non Pressurized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Container
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Nasal Drug Delivery Mode Market, By System Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Multi- Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Bi-Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Unit Dose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Nasal Drug Delivery Mode Market, By End Users, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Nasal Drug Delivery Mode Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

10. Global Nasal Drug Delivery Mode Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

11. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GlaxoSmithKline plc (GSK)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mystic Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Johnson & Johnson Services Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PendoPharm Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- 3M Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cadila Pharmaceuticals Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- OptiNose Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- ENT Technologies Pty Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Neurelis Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- AptarGroup, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Becton, Dickinson and Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views